nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—HSD17B1—Steroid Biosynthesis—HSD17B4—epilepsy syndrome	0.16	0.235	CbGpPWpGaD
Equilin—HSD17B1—head—epilepsy syndrome	0.056	0.206	CbGeAlD
Equilin—HSD17B1—nervous system—epilepsy syndrome	0.0531	0.195	CbGeAlD
Equilin—HSD17B1—central nervous system—epilepsy syndrome	0.0511	0.188	CbGeAlD
Equilin—HSD17B1—brain—epilepsy syndrome	0.0406	0.149	CbGeAlD
Equilin—SHBG—Nongenotropic Androgen signaling—GNAO1—epilepsy syndrome	0.0328	0.0482	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—CYP11A1—epilepsy syndrome	0.0302	0.0444	CbGpPWpGaD
Equilin—SHBG—hindbrain—epilepsy syndrome	0.0298	0.11	CbGeAlD
Equilin—SHBG—Nongenotropic Androgen signaling—PLCB1—epilepsy syndrome	0.0186	0.0274	CbGpPWpGaD
Equilin—SHBG—brainstem—epilepsy syndrome	0.0171	0.0629	CbGeAlD
Equilin—SHBG—Nongenotropic Androgen signaling—CDC42—epilepsy syndrome	0.0158	0.0233	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—POMC—epilepsy syndrome	0.0133	0.0196	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—FOS—epilepsy syndrome	0.0102	0.015	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.00944	0.0139	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.00944	0.0139	CbGpPWpGaD
Equilin—Estriol—SLCO1A2—epilepsy syndrome	0.00932	0.191	CrCbGaD
Equilin—Dezocine—OPRM1—epilepsy syndrome	0.00897	0.184	CrCbGaD
Equilin—SHBG—central nervous system—epilepsy syndrome	0.00861	0.0317	CbGeAlD
Equilin—SHBG—cerebellum—epilepsy syndrome	0.00842	0.031	CbGeAlD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.00715	0.0105	CbGpPWpGaD
Equilin—SHBG—brain—epilepsy syndrome	0.00684	0.0252	CbGeAlD
Equilin—HSD17B1—Diseases associated with visual transduction—APOE—epilepsy syndrome	0.00667	0.00981	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—SRC—epilepsy syndrome	0.00658	0.00968	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.00654	0.00963	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.0063	0.00927	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.00572	0.00841	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CA13—epilepsy syndrome	0.00555	0.00816	CbGpPWpGaD
Equilin—HSD17B1—Disease—PDXK—epilepsy syndrome	0.00502	0.00739	CbGpPWpGaD
Equilin—HSD17B1—Disease—PNPO—epilepsy syndrome	0.00459	0.00675	CbGpPWpGaD
Equilin—HSD17B1—Disease—NHLRC1—epilepsy syndrome	0.00459	0.00675	CbGpPWpGaD
Equilin—HSD17B1—Disease—EPM2A—epilepsy syndrome	0.00459	0.00675	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.00446	0.00657	CbGpPWpGaD
Equilin—Conjugated Estrogens—SLCO1A2—epilepsy syndrome	0.00445	0.0911	CrCbGaD
Equilin—Estrone—SLCO1A2—epilepsy syndrome	0.00444	0.0908	CrCbGaD
Equilin—HSD17B1—Disease—SV2A—epilepsy syndrome	0.00427	0.00628	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CERS1—epilepsy syndrome	0.0042	0.00619	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—L2HGDH—epilepsy syndrome	0.0042	0.00619	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GLUD1—epilepsy syndrome	0.0042	0.00619	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FAR1—epilepsy syndrome	0.0042	0.00619	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PDXK—epilepsy syndrome	0.0042	0.00619	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ADK—epilepsy syndrome	0.0042	0.00619	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—AKT1—epilepsy syndrome	0.00409	0.00601	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PNPO—epilepsy syndrome	0.00384	0.00566	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NHLRC1—epilepsy syndrome	0.00384	0.00566	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GAMT—epilepsy syndrome	0.00384	0.00566	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—EPM2A—epilepsy syndrome	0.00384	0.00566	CbGpPWpGaD
Equilin—HSD17B1—Disease—PFKL—epilepsy syndrome	0.0038	0.0056	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CA4—epilepsy syndrome	0.00357	0.00526	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—QDPR—epilepsy syndrome	0.00357	0.00526	CbGpPWpGaD
Equilin—HSD17B1—Disease—STX1B—epilepsy syndrome	0.00348	0.00512	CbGpPWpGaD
Equilin—Estradiol—SLCO1A2—epilepsy syndrome	0.00336	0.0688	CrCbGaD
Equilin—HSD17B1—Metabolism—COX3—epilepsy syndrome	0.00336	0.00494	CbGpPWpGaD
Equilin—HSD17B1—Disease—PPP1R3C—epilepsy syndrome	0.00323	0.00476	CbGpPWpGaD
Equilin—HSD17B1—Disease—CPSF4—epilepsy syndrome	0.00323	0.00476	CbGpPWpGaD
Equilin—HSD17B1—Disease—GBE1—epilepsy syndrome	0.00323	0.00476	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRDM4—epilepsy syndrome	0.00321	0.00473	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.00321	0.00473	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CACNA2D2—epilepsy syndrome	0.00319	0.00469	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—KCNB1—epilepsy syndrome	0.00319	0.00469	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PFKL—epilepsy syndrome	0.00319	0.00469	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLCO1A2—epilepsy syndrome	0.00319	0.00469	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC6A8—epilepsy syndrome	0.00319	0.00469	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.00311	0.00458	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.00309	0.00455	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NEU1—epilepsy syndrome	0.00291	0.00429	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—UPB1—epilepsy syndrome	0.00291	0.00429	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ATIC—epilepsy syndrome	0.00291	0.00429	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ACKR4—epilepsy syndrome	0.00281	0.00413	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD17B4—epilepsy syndrome	0.0028	0.00413	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GBE1—epilepsy syndrome	0.00271	0.00399	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPP1R3C—epilepsy syndrome	0.00271	0.00399	CbGpPWpGaD
Equilin—HSD17B1—Disease—ST3GAL3—epilepsy syndrome	0.00269	0.00396	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.00265	0.0039	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ASAH1—epilepsy syndrome	0.00255	0.00375	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SSTR4—epilepsy syndrome	0.00254	0.00374	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SSTR5—epilepsy syndrome	0.00254	0.00374	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—STXBP1—epilepsy syndrome	0.00248	0.00365	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR10—epilepsy syndrome	0.00244	0.00358	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ABCC2—epilepsy syndrome	0.00244	0.0499	CrCbGaD
Equilin—HSD17B1—Metabolism—ALAD—epilepsy syndrome	0.00241	0.00355	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NT5E—epilepsy syndrome	0.00241	0.00355	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CACNA1A—epilepsy syndrome	0.0023	0.00339	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALDH7A1—epilepsy syndrome	0.0023	0.00339	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ST3GAL3—epilepsy syndrome	0.00225	0.00332	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ADSL—epilepsy syndrome	0.00221	0.00325	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GLUL—epilepsy syndrome	0.00217	0.00319	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRM2—epilepsy syndrome	0.00213	0.00313	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCC2—epilepsy syndrome	0.00213	0.0436	CrCbGaD
Equilin—HSD17B1—Metabolism—CACNA1D—epilepsy syndrome	0.00213	0.00313	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TXNRD1—epilepsy syndrome	0.00199	0.00293	CbGpPWpGaD
Equilin—HSD17B1—Disease—EIF2AK2—epilepsy syndrome	0.00196	0.00288	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AQP1—epilepsy syndrome	0.00193	0.00284	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SSTR3—epilepsy syndrome	0.00193	0.00283	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.00188	0.00277	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCG2—epilepsy syndrome	0.00188	0.0385	CrCbGaD
Equilin—Estrone—ABCG2—epilepsy syndrome	0.00188	0.0384	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.00185	0.00273	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR9—epilepsy syndrome	0.00185	0.00272	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.00185	0.00272	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPY2R—epilepsy syndrome	0.00185	0.00272	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SSTR1—epilepsy syndrome	0.00185	0.00272	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR8—epilepsy syndrome	0.00185	0.00272	CbGpPWpGaD
Equilin—HSD17B1—Disease—PPIA—epilepsy syndrome	0.00181	0.00267	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRM3—epilepsy syndrome	0.00181	0.00266	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRM4—epilepsy syndrome	0.00181	0.00266	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DUSP4—epilepsy syndrome	0.00178	0.00262	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SSTR2—epilepsy syndrome	0.00178	0.00262	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CHRM3—epilepsy syndrome	0.00175	0.00257	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—KCNJ11—epilepsy syndrome	0.00175	0.00257	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRM8—epilepsy syndrome	0.00172	0.00253	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PGF—epilepsy syndrome	0.00172	0.00253	CbGpPWpGaD
Equilin—Estriol—ABCB1—epilepsy syndrome	0.00164	0.0336	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—OPRD1—epilepsy syndrome	0.00164	0.00241	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNAO1—epilepsy syndrome	0.00164	0.00241	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.00163	0.00239	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.00159	0.00234	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRM1—epilepsy syndrome	0.00157	0.00231	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CHRM1—epilepsy syndrome	0.00157	0.00231	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDYN—epilepsy syndrome	0.00157	0.00231	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR7—epilepsy syndrome	0.00157	0.00231	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GAL—epilepsy syndrome	0.00148	0.00217	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GFAP—epilepsy syndrome	0.00148	0.00217	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRM5—epilepsy syndrome	0.00146	0.00215	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CHRM3—epilepsy syndrome	0.00146	0.00215	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP2—epilepsy syndrome	0.00146	0.00215	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCG2—epilepsy syndrome	0.00142	0.00209	CbGpPWpGaD
Equilin—Estradiol—ABCG2—epilepsy syndrome	0.00142	0.0291	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—CX3CR1—epilepsy syndrome	0.0014	0.00206	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2C19—epilepsy syndrome	0.00139	0.00204	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP11A1—epilepsy syndrome	0.00138	0.00203	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CX3CL1—epilepsy syndrome	0.00137	0.00202	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BDKRB1—epilepsy syndrome	0.00137	0.00202	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CHRM2—epilepsy syndrome	0.00137	0.00202	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.00137	0.00201	CbGpPWpGaD
Equilin—HSD17B1—Disease—SLC2A1—epilepsy syndrome	0.00134	0.00198	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GABBR1—epilepsy syndrome	0.00133	0.00196	CbGpPWpGaD
Equilin—HSD17B1—Disease—JUNB—epilepsy syndrome	0.00133	0.00196	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS1—epilepsy syndrome	0.00132	0.00195	CbGpPWpGaD
Equilin—Estropipate—ALB—epilepsy syndrome	0.00131	0.0269	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—HRH3—epilepsy syndrome	0.00128	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Disease—HBEGF—epilepsy syndrome	0.00126	0.00186	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—OPRM1—epilepsy syndrome	0.00126	0.00185	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.00125	0.00184	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2D6—epilepsy syndrome	0.00124	0.00183	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT3—epilepsy syndrome	0.00124	0.00182	CbGpPWpGaD
Equilin—HSD17B1—Disease—ADAM10—epilepsy syndrome	0.00121	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR3—epilepsy syndrome	0.00119	0.00175	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ADRA2A—epilepsy syndrome	0.00118	0.00174	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—BCHE—epilepsy syndrome	0.00118	0.00173	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPY—epilepsy syndrome	0.00116	0.00171	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ATP2A2—epilepsy syndrome	0.00116	0.00171	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDC42—epilepsy syndrome	0.00113	0.00166	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC2A1—epilepsy syndrome	0.00112	0.00166	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL2—epilepsy syndrome	0.00112	0.00165	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HSPB1—epilepsy syndrome	0.00112	0.00165	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL3—epilepsy syndrome	0.00112	0.00165	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—OXT—epilepsy syndrome	0.00112	0.00165	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CRH—epilepsy syndrome	0.00112	0.00165	CbGpPWpGaD
Equilin—Estradiol—CYP2C19—epilepsy syndrome	0.00112	0.0229	CrCbGaD
Equilin—HSD17B1—Metabolism—PLCB1—epilepsy syndrome	0.00111	0.00164	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TH—epilepsy syndrome	0.00111	0.00163	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.00109	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTK2B—epilepsy syndrome	0.00104	0.00153	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TSC1—epilepsy syndrome	0.00104	0.00153	CbGpPWpGaD
Equilin—HSD17B1—Disease—HES1—epilepsy syndrome	0.00104	0.00152	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SST—epilepsy syndrome	0.00101	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NTRK2—epilepsy syndrome	0.00101	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR2—epilepsy syndrome	0.00101	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Disease—FYN—epilepsy syndrome	0.00101	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Disease—H2AFX—epilepsy syndrome	0.001	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DUSP6—epilepsy syndrome	0.001	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRA2A—epilepsy syndrome	0.00099	0.00146	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLAT—epilepsy syndrome	0.000986	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Disease—YWHAZ—epilepsy syndrome	0.000968	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000951	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL12—epilepsy syndrome	0.000951	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JUNB—epilepsy syndrome	0.000934	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CNR1—epilepsy syndrome	0.000934	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Disease—CCR5—epilepsy syndrome	0.000931	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLCB1—epilepsy syndrome	0.00093	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HMOX1—epilepsy syndrome	0.000925	0.00136	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CAT—epilepsy syndrome	0.000913	0.00134	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR7—epilepsy syndrome	0.000911	0.00134	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ABCB1—epilepsy syndrome	0.000896	0.0183	CrCbGaD
Equilin—HSD17B1—Metabolism—ABCB1—epilepsy syndrome	0.000888	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HBEGF—epilepsy syndrome	0.000884	0.0013	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT3—epilepsy syndrome	0.000868	0.00128	CbGpPWpGaD
Equilin—HSD17B1—Disease—TSC2—epilepsy syndrome	0.000866	0.00127	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADAM10—epilepsy syndrome	0.000848	0.00125	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOE—epilepsy syndrome	0.000847	0.00125	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPX1—epilepsy syndrome	0.000826	0.00121	CbGpPWpGaD
Equilin—Estrone—ALB—epilepsy syndrome	0.000818	0.0167	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—S100B—epilepsy syndrome	0.000802	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6ST—epilepsy syndrome	0.000796	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SOCS3—epilepsy syndrome	0.000794	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDC42—epilepsy syndrome	0.000792	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS2—epilepsy syndrome	0.000789	0.00116	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCB1—epilepsy syndrome	0.000783	0.016	CrCbGaD
Equilin—Estrone—ABCB1—epilepsy syndrome	0.000781	0.016	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—AVP—epilepsy syndrome	0.000767	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HES1—epilepsy syndrome	0.000725	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AGT—epilepsy syndrome	0.000724	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOE—epilepsy syndrome	0.000709	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FYN—epilepsy syndrome	0.000705	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—H2AFX—epilepsy syndrome	0.000703	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MEF2C—epilepsy syndrome	0.000701	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000678	0.000997	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NGF—epilepsy syndrome	0.00067	0.000986	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR5—epilepsy syndrome	0.000652	0.000959	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF2—epilepsy syndrome	0.000643	0.000947	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR2A—epilepsy syndrome	0.000638	0.000939	CbGpPWpGaD
Equilin—Estradiol—ALB—epilepsy syndrome	0.00062	0.0127	CrCbGaD
Equilin—HSD17B1—Metabolism—POMC—epilepsy syndrome	0.000609	0.000897	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TSC2—epilepsy syndrome	0.000606	0.000892	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AGT—epilepsy syndrome	0.000605	0.000891	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOE—epilepsy syndrome	0.000593	0.000873	CbGpPWpGaD
Equilin—Estradiol—ABCB1—epilepsy syndrome	0.000592	0.0121	CrCbGaD
Equilin—HSD17B1—Disease—MTOR—epilepsy syndrome	0.000586	0.000862	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KDR—epilepsy syndrome	0.000581	0.000855	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—epilepsy syndrome	0.00058	0.000854	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCB—epilepsy syndrome	0.000559	0.000823	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6ST—epilepsy syndrome	0.000557	0.00082	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALB—epilepsy syndrome	0.000556	0.000817	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—POMC—epilepsy syndrome	0.00051	0.00075	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL2—epilepsy syndrome	0.000499	0.000734	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS2—epilepsy syndrome	0.000486	0.000715	CbGpPWpGaD
Equilin—HSD17B1—Disease—SRC—epilepsy syndrome	0.000469	0.000691	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF2—epilepsy syndrome	0.000451	0.000663	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RELA—epilepsy syndrome	0.000418	0.000615	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MTOR—epilepsy syndrome	0.00041	0.000603	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—epilepsy syndrome	0.000377	0.000555	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JUN—epilepsy syndrome	0.000366	0.000539	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—epilepsy syndrome	0.000357	0.000525	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SRC—epilepsy syndrome	0.000329	0.000484	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—epilepsy syndrome	0.00032	0.000471	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—epilepsy syndrome	0.000292	0.000429	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—epilepsy syndrome	0.000244	0.000359	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—epilepsy syndrome	0.000204	0.000301	CbGpPWpGaD
